Market revenue in 2023 | USD 25.9 million |
Market revenue in 2030 | USD 50.7 million |
Growth rate | 10.1% (CAGR from 2023 to 2030) |
Largest segment | Blood sample |
Fastest growing segment | Blood Sample |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Blood Sample |
Key market players worldwide | ANGLE PLC, Guardant Health Inc, Myriad Genetics Inc, Biocept Inc, Lucence Health, Roche, Qiagen NV, Illumina Inc, Thermo Fisher Scientific Inc, Epigenomics AG, Oncimmune, Freenome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liquid biopsy market will help companies and investors design strategic landscapes.
Blood sample was the largest segment with a revenue share of 73.36% in 2023. Horizon Databook has segmented the South Africa liquid biopsy market based on blood sample covering the revenue growth of each sub-segment from 2018 to 2030.
The South Africa liquid biopsy market is competitive owing to the presence of a blend of global players and local manufacturers. Some of the leading liquid biopsy providers in the country are PathCare, Axaitech, QIAGEN, and Guardant Health, among others.
In addition, the presence of a large number of profit and nonprofit organizations that promote awareness about cancer screening and diagnosis is expected to support market expansion further.
Moreover, certain initiatives undertaken by leading participants are anticipated to fuel market expansion. For instance, in October 2021, Illumina, Inc., a leader in sequencing technology, announced its plans to launch an innovative liquid biopsy test through its company GRAIL in African markets.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa liquid biopsy market , including forecasts for subscribers. This country databook contains high-level insights into South Africa liquid biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account